バルブ化における細胞外核酸の新たな役割:アトルバスタチンの潜在的な標的
Lana Osman1, Adrian H Chester, Mohamed Amrani
1Imperial College, Royal Brompton and Harefield National Health Service Trust, Harefield, Middlesex, UK.
Circulation
|July 6, 2006
まとめ
細胞外ATPは,ヒトのバルブ細胞におけるオステオブラストの分化を促進し,アデノシンは抑制作用を有する. これは,カルシフ性大動脈弁疾患の新たな治療目標を示唆しています.
科学分野:
- 心血管生物学 心血管生物学
- バイオケミストリー バイオケミストリー
- 細胞生物学 細胞生物学
背景:
- カルシフ性大動脈弁疾患は,炎症とオステオブラストのような細胞を伴う.
- 細胞外ATPとアデノシンは,骨の改造と炎症に関与しています.
- 大動脈弁疾患における細胞メカニズムは不明である.
研究 の 目的:
- ヒト弁間細胞のオステオブラスト分化における細胞外ATPとアデノシンの役割を調査する.
- カルシフ性大動脈弁疾患の潜在的な治療標的を調査する.
主な方法:
- 主要なヒト弁間細胞 (ICs) を培養し,骨質媒介,ATP,ATP-gamma-S,アデノシンを21日間投与した.
- アルカリリンフォスファターゼ (ALP) の活性と発現は,スペクトロフォトメトリーと免疫細胞化学を用いて測定されました.
- アトロバスタチンの治療がALPの活性とATPの分解に及ぼす効果を評価した.
主要な成果:
- ATPとATP-gamma-Sは,バルブICでALPの活性と発現を著しく増加させた.
- アデノシン単独はALPの活動に影響を与えなかったが,オステオゲン媒介誘発ALPを減少させた.
- アトルバスタチンは,ATP誘発のALP活性を抑制し,アデノシンへのATP分解を増加させた.
結論:
- 細胞外核酸は,ヒトのバルブICにおけるオステオブラストの微分化を誘導する新しい役割を果たします.
- これらの発見は,カルシフ性大動脈弁疾患の進行を予防するための潜在的な治療戦略を提供します.
関連する概念動画
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
783
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
783
Feedback Regulation of Calcium Concentration
4.2K
Calcium is an essential signaling molecule required for various cellular functions. Calcium pumps and ion channels on cell and organellar membranes, such as those on the endoplasmic reticulum (ER), regulate calcium concentrations inside the cell. They remain closed, keeping the cytosolic calcium levels low at a resting state.
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
4.2K
Antihypertensive Drugs: Action of Calcium Channel Blockers
2.2K
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
2.2K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.8K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.8K
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
1.8K
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
1.8K
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
2.6K
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
2.6K


